Clinical trial
Tofacitnib for the Treatment of Alopecia Areata and Variants
NCT02197455 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tofacitnib for the Treatment of Alopecia Areata and Variants
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- July 31, 2015
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia areata (aa), alopecia totalis (at), alopecia universalis (au)